Kalra Balkrishan 4
4 · Genpact LTD · Filed Dec 17, 2024
Insider Transaction Report
Form 4
Kalra Balkrishan
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-12-13−13,600→ 56,400 totalExercise: $27.65Exp: 2026-03-31→ Common Shares (13,600 underlying) - Exercise/Conversion
Common Shares
2024-12-13$27.65/sh+13,600$376,040→ 281,004 total - Sale
Common Shares
2024-12-13$44.60/sh−13,600$606,560→ 267,404 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024.
- [F2]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.47 to $44.78. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The option vested 50% on January 10, 2019 and the remainder on January 10, 2021.